Skip to main content
Top
Published in: Inflammation 3/2008

01-06-2008

Anti-inflammatory Effects of Ethanol Extract from Kummerowia striata (Thunb.) Schindl on LPS-Stimulated RAW 264.7 Cell

Authors: Jun-Yan Tao, Lei Zhao, Zhi-Jun Huang, Xiao-Yu Zhang, Shu-Ling Zhang, Qiong-Guang Zhang, Fei-Xiao, Bao-Hui Zhang, Qi-Lin Feng, Guo-Hua Zheng

Published in: Inflammation | Issue 3/2008

Login to get access

Abstract

Kummerowia striata (Thunb.) Schindl has long been used as a fork herb in inflammation-related therapy. This study was undertaken to determine the anti-inflammatory effect of the plant. High performance liquid chromatography (HPLC) was used for evaluating the extract. While dexamethasone (DM) was used as a positive control, the effects of ethanol extract on the production of IL-1β, IL-6, NO, COX-2 and TNF-α, the expression of iNOS mRNA, TNF-α mRNA, COX-2 mRNA, protein production of COX-2 and HO-1, NF-κB and I-κB of LPS-stimulated RAW 264.7 cells were studied by sandwich ELISA, real-time PCR, Western blot analysis and immunocytochemistry assay respectively. The results showed that K. striata (Thunb.) Schindl had a good anti-inflammatory effect on LPS-stimulated RAW264.7 cell. On one hand, it could significantly inhibit the production of IL-1β, IL-6, NO, TNF-α, COX-2 in LPS-stimulated cell than that of single LPS stimulated cell (p < 0.01 or p < 0.05). On the other hand, it could increase the production of IL-10 and HO-1 than that of single LPS intervention cell (p < 0.01 or p < 0.05). Furthermore, the extract also could inhibit the production of NF-κB and I-κB compared to single LPS stimulated cell. In a word, it suggested that the anti-inflammatory actions of K. striata (Thunb.) Schindl ethanol extract might be due to the down-regulation of IL-1β, IL-6, NO, TNF-α and COX-2 via the suppression of NF-κB activation and conversation of I-κB production, and another pathway was up regulating the production of IL-10 and HO-1.
Literature
1.
go back to reference Lundberg, I. E. 2000. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2:216–224.PubMedCrossRef Lundberg, I. E. 2000. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2:216–224.PubMedCrossRef
2.
3.
go back to reference Rochon, Y. P., and M. M. Frojmovic. 1992. A model for the recruitment of neutrophils at sites of inflammation. Physiological relevance of in vivo neutrophil aggregation. Med. Hypotheses 38:132–138.PubMedCrossRef Rochon, Y. P., and M. M. Frojmovic. 1992. A model for the recruitment of neutrophils at sites of inflammation. Physiological relevance of in vivo neutrophil aggregation. Med. Hypotheses 38:132–138.PubMedCrossRef
4.
go back to reference Lowe, J. B. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. 15:531–538.PubMedCrossRef Lowe, J. B. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. 15:531–538.PubMedCrossRef
5.
go back to reference Gallucci, S., C. Provenzano, P. Mazzarelli, F. Scuderi, and E. Bartoccioni. 1998. Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 10:267–273.PubMedCrossRef Gallucci, S., C. Provenzano, P. Mazzarelli, F. Scuderi, and E. Bartoccioni. 1998. Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 10:267–273.PubMedCrossRef
6.
go back to reference Kim, S. S., O. J. Oh, H. Y. Min, P. Eun-Jung, K. Youngleem, J. P. Hyen, N. H. Yong, and K. L. Sang. 2003. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci. 73:337–348.PubMedCrossRef Kim, S. S., O. J. Oh, H. Y. Min, P. Eun-Jung, K. Youngleem, J. P. Hyen, N. H. Yong, and K. L. Sang. 2003. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci. 73:337–348.PubMedCrossRef
7.
go back to reference New Medicine College of Jiangsu. 1977. Dictionary of Chinese traditional medicine (part 1). Shanghai, Shanghai People Publishing Company 1215. New Medicine College of Jiangsu. 1977. Dictionary of Chinese traditional medicine (part 1). Shanghai, Shanghai People Publishing Company 1215.
8.
go back to reference Ogborne, R. M., S. A. Rushworth, C. A. Charalambos, and M. A. O’Connell. 2004. Heme oxygenase-1: a target for dietary antioxidants. Biochem. Soc. Trans. 32:1003–1005.PubMedCrossRef Ogborne, R. M., S. A. Rushworth, C. A. Charalambos, and M. A. O’Connell. 2004. Heme oxygenase-1: a target for dietary antioxidants. Biochem. Soc. Trans. 32:1003–1005.PubMedCrossRef
9.
go back to reference Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 126:131–138.PubMedCrossRef Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 126:131–138.PubMedCrossRef
10.
go back to reference Livak, K. J., and T. D. Schmittgen. 2000. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25:402–408.CrossRef Livak, K. J., and T. D. Schmittgen. 2000. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25:402–408.CrossRef
11.
go back to reference World Health Organization. 1991. Guidelines for the assessment of herbal medicines. Munich 28:6. World Health Organization. 1991. Guidelines for the assessment of herbal medicines. Munich 28:6.
12.
go back to reference Jia, Y. B., Q. S. Xu, Y. Z. Hu, and V. H. Yvan. 2005. Development, optimization and validation of a fingerprint of Ginkgo biloba extracts by high-performance liquid chromatography. J. Chromatogr. A. 1066:97–104.CrossRef Jia, Y. B., Q. S. Xu, Y. Z. Hu, and V. H. Yvan. 2005. Development, optimization and validation of a fingerprint of Ginkgo biloba extracts by high-performance liquid chromatography. J. Chromatogr. A. 1066:97–104.CrossRef
13.
go back to reference Zhao, L. H., C. Y. Huang, Z. Shan, B. R. Xiang, and L. H. Mei. 2005. Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC-MS. J. Chromatogr. B. 821:67–74.CrossRef Zhao, L. H., C. Y. Huang, Z. Shan, B. R. Xiang, and L. H. Mei. 2005. Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC-MS. J. Chromatogr. B. 821:67–74.CrossRef
14.
go back to reference Yang, L. W., D. H. Wu, X. Tang, W. Peng, X. R. Wang, Y. Ma, and W. W. Su. 2005. Fingerprint quality control of Tianjihuang by high-performance liquid chromatography-photodiode array detection. J. Chromatogr. A. 1070:35–42.PubMedCrossRef Yang, L. W., D. H. Wu, X. Tang, W. Peng, X. R. Wang, Y. Ma, and W. W. Su. 2005. Fingerprint quality control of Tianjihuang by high-performance liquid chromatography-photodiode array detection. J. Chromatogr. A. 1070:35–42.PubMedCrossRef
15.
go back to reference Ueda, H., C. Yamazaki, and M. Yamazaki. 2002. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol. Pharm. Bull. 25:1197–202.PubMedCrossRef Ueda, H., C. Yamazaki, and M. Yamazaki. 2002. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol. Pharm. Bull. 25:1197–202.PubMedCrossRef
16.
go back to reference Eigler, A., T. F. Greten, B. Sinha, C. Haslberger, G. W. Sullivan, and S. Endres. 1997. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand. J. Immunol. 45:132–139.PubMedCrossRef Eigler, A., T. F. Greten, B. Sinha, C. Haslberger, G. W. Sullivan, and S. Endres. 1997. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand. J. Immunol. 45:132–139.PubMedCrossRef
17.
go back to reference Payne, D. N. 2003. Nitric oxide in allergic airway inflammation. Curr. Opin. Allergy Clin. Immunol. 3:133–137.PubMedCrossRef Payne, D. N. 2003. Nitric oxide in allergic airway inflammation. Curr. Opin. Allergy Clin. Immunol. 3:133–137.PubMedCrossRef
18.
go back to reference Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12:4685–4695.PubMed Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12:4685–4695.PubMed
19.
go back to reference Yoo, H. H., T. Kim, S. Ahn, Y. J. Kim, H. Y. Kim, X. L. Piao, and J. H. Park. 2005. Evaluation of the estrogenic activity of Leguminosae plants. Biol. Pharm. Bull. 28:538–540.PubMedCrossRef Yoo, H. H., T. Kim, S. Ahn, Y. J. Kim, H. Y. Kim, X. L. Piao, and J. H. Park. 2005. Evaluation of the estrogenic activity of Leguminosae plants. Biol. Pharm. Bull. 28:538–540.PubMedCrossRef
20.
go back to reference Yuan, Y. M. 1994. Influence keratopathycured by Kummerowia striata (Thunb.) Schindl. J. Hennan Medicine College 86:16. Yuan, Y. M. 1994. Influence keratopathycured by Kummerowia striata (Thunb.) Schindl. J. Hennan Medicine College 86:16.
21.
go back to reference Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zahringer, U. Seydel, and P. F. Di. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217–225.PubMed Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zahringer, U. Seydel, and P. F. Di. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217–225.PubMed
22.
go back to reference Moffat, F. L., T. Han, Z. M. Li, M. D. Peck, W. Jy, Y. S. Ahn, A. J. Chu, and L. Y. Bourguignon. 1996. Supplemental L-arginine HCl augments bacterial phagocytosis in human polymorphonuclear leukocytes. J. Cell. Physiol. 168:26–33.PubMedCrossRef Moffat, F. L., T. Han, Z. M. Li, M. D. Peck, W. Jy, Y. S. Ahn, A. J. Chu, and L. Y. Bourguignon. 1996. Supplemental L-arginine HCl augments bacterial phagocytosis in human polymorphonuclear leukocytes. J. Cell. Physiol. 168:26–33.PubMedCrossRef
23.
go back to reference Reddy, S. T., and H. R. Herschman. 1994. Ligand-induced prostaglandin synthase requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblast and macrophages. J. Biol. Chem. 269:473–80. Reddy, S. T., and H. R. Herschman. 1994. Ligand-induced prostaglandin synthase requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblast and macrophages. J. Biol. Chem. 269:473–80.
24.
go back to reference Lee, S. H., E. Soyoola, P. Chanmugam, S. Hart, W. Sun, H. Zhong et al. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:934–938. Lee, S. H., E. Soyoola, P. Chanmugam, S. Hart, W. Sun, H. Zhong et al. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:934–938.
25.
go back to reference Takahashi, T., K. Morita, R. Akagi, and S. Sassa. 2004. Protective role of heme oxygenase-1 in renal ischemia. Antioxid. Redox Signal 26:867–877. Takahashi, T., K. Morita, R. Akagi, and S. Sassa. 2004. Protective role of heme oxygenase-1 in renal ischemia. Antioxid. Redox Signal 26:867–877.
26.
go back to reference Otterbein, L. E., M. P. Soares, K. Yamashita, and F. H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449–455.PubMedCrossRef Otterbein, L. E., M. P. Soares, K. Yamashita, and F. H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449–455.PubMedCrossRef
27.
go back to reference Gibbons, S. J., and G. Farrugia. 2004. The role of carbon monoxide in the gastrointestinal tract. J. Physiol. 556:325–326.PubMedCrossRef Gibbons, S. J., and G. Farrugia. 2004. The role of carbon monoxide in the gastrointestinal tract. J. Physiol. 556:325–326.PubMedCrossRef
28.
go back to reference Haider, A., R. Olszanecki, R. Gryglewski, M. L.M. L. Schwartzman, E. Lianos, A. Kappas, A. Nasjletti, and N. G. Abraham. 2002. Regulation of cyclooxygenase by the heme–heme oxygenase system in microvessel endothelial cells. J. Pharmacol. Exp. Ther. 300:188–194.PubMedCrossRef Haider, A., R. Olszanecki, R. Gryglewski, M. L.M. L. Schwartzman, E. Lianos, A. Kappas, A. Nasjletti, and N. G. Abraham. 2002. Regulation of cyclooxygenase by the heme–heme oxygenase system in microvessel endothelial cells. J. Pharmacol. Exp. Ther. 300:188–194.PubMedCrossRef
29.
go back to reference Shapira, L., W. A. Soskolne, Y. Houri, V. Barak, A. Halabi, and A. Stabholz. 1996. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64:825–828.PubMed Shapira, L., W. A. Soskolne, Y. Houri, V. Barak, A. Halabi, and A. Stabholz. 1996. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64:825–828.PubMed
30.
go back to reference Lawrence, T., D. W. Gilroy, P. R. Colville-Nash, and D. A. Willoughby. 2001. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7:1291–1297.PubMedCrossRef Lawrence, T., D. W. Gilroy, P. R. Colville-Nash, and D. A. Willoughby. 2001. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7:1291–1297.PubMedCrossRef
31.
go back to reference Riehemann, K., B. Behnke, and K. Schulze-Osthoff. 1999. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-κB. FEBS Lett. 442:89–94.PubMedCrossRef Riehemann, K., B. Behnke, and K. Schulze-Osthoff. 1999. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-κB. FEBS Lett. 442:89–94.PubMedCrossRef
32.
go back to reference Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135–142.PubMedCrossRef Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135–142.PubMedCrossRef
33.
go back to reference Renard, P., and M. Raes. 1999. The proinflammatory transcription factor NF-κB: a potential target for novel therapeutical strategies. Cell biol. Toxicol. l15:341–344.CrossRef Renard, P., and M. Raes. 1999. The proinflammatory transcription factor NF-κB: a potential target for novel therapeutical strategies. Cell biol. Toxicol. l15:341–344.CrossRef
34.
go back to reference Ter Steege, J. C., M. W. Van de Ven, P. P. Forget, P. Brouckaert, and W. A. Buurman. 1998. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model. Cytokine 10:115–123.PubMedCrossRef Ter Steege, J. C., M. W. Van de Ven, P. P. Forget, P. Brouckaert, and W. A. Buurman. 1998. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model. Cytokine 10:115–123.PubMedCrossRef
35.
go back to reference Chan, E. D., and D. W. H. Riches. 2001. IFN-γ +LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mark in a mouse macrophage cell line. Am. J. Physiol., Cell. Physiol. 280:441–450. Chan, E. D., and D. W. H. Riches. 2001. IFN-γ +LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mark in a mouse macrophage cell line. Am. J. Physiol., Cell. Physiol. 280:441–450.
36.
go back to reference Tilg, H., A. Wilmer, W. Vogel, M. Herold, B. Nolchen, G. Judmaier, and C. Huber. 1992. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274.PubMed Tilg, H., A. Wilmer, W. Vogel, M. Herold, B. Nolchen, G. Judmaier, and C. Huber. 1992. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274.PubMed
37.
go back to reference Coker, R. K., and G. J. Laurent. 1998. Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 11:1218–1221.PubMedCrossRef Coker, R. K., and G. J. Laurent. 1998. Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 11:1218–1221.PubMedCrossRef
38.
go back to reference Lind, L. 2003. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169:203–214.PubMedCrossRef Lind, L. 2003. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169:203–214.PubMedCrossRef
39.
go back to reference Bertolini, A., A. Ottani, and M. Sandrini. 2001. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol. Res. 44:437–450.PubMedCrossRef Bertolini, A., A. Ottani, and M. Sandrini. 2001. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol. Res. 44:437–450.PubMedCrossRef
40.
go back to reference Kim, K. M., Y. G. Kwon, H. T. Chung, Y. G. Yun, H. O. Pae, J. A. Han et al. 2003. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol. Appl. Pharmacol. 190:1–8.PubMedCrossRef Kim, K. M., Y. G. Kwon, H. T. Chung, Y. G. Yun, H. O. Pae, J. A. Han et al. 2003. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol. Appl. Pharmacol. 190:1–8.PubMedCrossRef
41.
go back to reference Zhao, L., J. Y. Tao, S. L. Zhang, R. Pang, F. Jin, J. H. Dong, and Y. J. Guo. 2007. Inner Anti-inflammatory Mechanisms of Petroleum Ether Extract from Melilotus suaveolens Ledeb. Inflammation Sep 1. Zhao, L., J. Y. Tao, S. L. Zhang, R. Pang, F. Jin, J. H. Dong, and Y. J. Guo. 2007. Inner Anti-inflammatory Mechanisms of Petroleum Ether Extract from Melilotus suaveolens Ledeb. Inflammation Sep 1.
Metadata
Title
Anti-inflammatory Effects of Ethanol Extract from Kummerowia striata (Thunb.) Schindl on LPS-Stimulated RAW 264.7 Cell
Authors
Jun-Yan Tao
Lei Zhao
Zhi-Jun Huang
Xiao-Yu Zhang
Shu-Ling Zhang
Qiong-Guang Zhang
Fei-Xiao
Bao-Hui Zhang
Qi-Lin Feng
Guo-Hua Zheng
Publication date
01-06-2008
Publisher
Springer US
Published in
Inflammation / Issue 3/2008
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-008-9061-7

Other articles of this Issue 3/2008

Inflammation 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.